SMITHKLINE BEECHAM P.L.C.

A GLOBAL FAMILY OF VACCINES

printed materials; namely, brochures, pamphlets, and record cards concerning vaccines;VACCINES;

ACCEL

pharmaceutical preparations, namely an analgesic and a cough cold preparation;

ALIROS

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue, and for vaccines;

ALONTRIL

pharmaceuticals and medicinal preparations to treat and/or prevent breast cancer and osteoporosis and to treat the vasomotor symptoms associated with menopause;

ARAFLO

pharmaceutical preparations for the treatment of urological and prostate related diseases and disorders;

ARIFLO

pharmaceutical and medicinal preparations and substances for the treatment of urological and prostate related diseases and disorders;

ARIFLO

pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system;

ARIFLO

AIR FLOW;Color is not claimed as a feature of the mark.;Healthcare Services;

ARIVEL

pharmaceutical preparations for the treatment of central nervous system related diseases and disorders;

ARIVOL

pharmaceutical preparations for the treatment of central nervous system related diseases and disorders;

ASTUTIN

pharmaceutical and medicinal preparations and substances; namely, medicinal preparations for the treatment of Parkinson's disease;

ASTUTIN

pharmaceutical and medicinal preparations and substances; namely, medicinal preparations for the treatment of Parkinson's disease;

ASTUTIN

pharmaceutical and medicinal preparations and substances for the treatment of central nervous system related diseases and disorders;

AVFLO

Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia, and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; and for vaccines;

AVIDART

pharmaceuticals to treat inflammatory disorders, and diseases of the immune system, for parenteral administration;

AVODART

pharmaceuticals to treat inflammatory disorders, and diseases of the immune system, for parenteral administration;

BRE-A-COL

pharmaceutical preparations, namely cold and cough medication;BRE A COL;

BRE-A-COL

Pharmaceutical preparations, namely, cold and cough medication;

COEFFEX

pharmaceutical preparations for use in treating cardiovascular related diseases and disorders;

COREGCONFIDENCE

Online information services pertaining to the treatment and management of cardivascular disease and disorders;

CORSODYL

medicated mouthwash and chewing gum and lozenges for dental hygiene;

CORSODYL

dentifrices and non-medicated mouthwash;

CORSODYL

Pharmaceutical preparations for use in the care and treatment of the teeth, gums and mouth;

CORSODYL

Dentifrices and mouthwashes;

CORVIM

pharmaceutical preparations for use in treating cardiovascular related diseases and disorders;

CR-RLS

PRINTED EDUCATIONAL MATERIALS, NAMELY PAMPHLETS AND BROCHURES, PERTAINING TO THE TREATMENT OF RESTLESS LEG SYNDROME;RLS;

DENAVIR

pharmaceutical preparations, namely, antivirals;The drawing is lined for the colors red and yellow/gold, and color is claimed as a feature of the mark.;

DENAVIR

pharmaceutical preparations; namely anti-viral preparations and preparations for the treatment of cold sores and related skin disorders;The drawing is lined for the colors red, blue and silver/gray; and varying shades of red/magenta, blue/cyan, yellow and silver within the swirl/wave design; and color is claimed as a feature of the mark;

DENAVIR

pharmaceutical preparations, namely, anti-viral preparations and preparations for the treatment of cold sores and related skin disorders;The drawing is lined for the colors red and silver/gray, and color is claimed as a feature of the mark.;

DENOVIR

pharmaceuticals; namely, anti-virals;

DENOVIR

pharmaceutical preparations, namely, anti-viral preparations;

DERMODYNAMIC

pharmaceutical preparations which facilitate drug absorption through the skin for use with a variety of medications;DERMO-DYNAMIC;non-medicated hair care preparations;

DUOFLO

Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia, obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; and for vaccines;

ELONTRIL

pharmaceuticals and medicinal preparations to treat and/or prevent breast cancer and osteoporosis and to treat the vasomotor symptoms associated with menopause;

EPRATENZ

pharmaceutical and medicinal preparations and substances for the treatment of cardiovascular related diseases and disorders;

EVOCAIR

pharmaceutical and medicinal preparations and substances for the treatment of respiratory related diseases and disorders;

EVODART

pharmaceuticals to treat inflammatory disorders, and diseases of the immune system, for parenteral administration;

EVOTOPIN

pharmaceutical and medicinal preparations used to treat cancer;

EVOTOPIN

Pharmaceutical and medicinal preparations for human use;

EXAFLO

pharmaceutical preparations for the treatment of urological related diseases and disorders;

FACITROL

pharmaceutical preparations for the treatment of central nervous system related diseases and disorders;

FACTIA

human pharmaceuticals, namely an anti-bacterial preparation;

FACTIA

pharmaceutical and medicinal preparations and substances, namely, an anti-bacterial preparation for human use;

FAMIV

pharmaceuticals; namely, anti-virals;

FAMVIR-T

anti-viral pharmaceutical preparations;

FLODART

Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia, and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; and for vaccines;

FYDREX

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue, and for vaccines;

HEZENIL

Human vaccines;

HEZENIL

Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations;

HYCAMTIN

information services, namely, providing on-line information related to the field of oncology by means of a global computer network;

INFORMED VIEW

providing medical and health related information to managed care organizations;

INFORMED VISIONS

providing medical and health related information to managed care organizations;

ISOCAMPTIN

pharmaceutical and medicinal preparations, namely for the treatment of cancer;

KINTROLE

pharmaceutical preparations for the treatment of central nervous system related diseases and disorders;

KIVEX

pharmaceutical preparations and substances for the treatment of metabolic and infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, musculoskeletal, cardiopulmonary, genitourinary, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations;

LABBENEFIT

LAB BENEFIT;clinical laboratory services offered directly to employers;

LUMAVEN

pharmaceutical and medicinal preparations and substances for human use, namely anti-virals and anti-infectives;

LUMAVER

pharmaceutical and medicinal preparations and substances for human use, namely anti-virals and anti-infectives;

LUMAVIR

pharmaceutical and medicinal preparations and substances for human use, namely, anti-virals and anti-infectives;

METHACRYL

pharmaceutical preparations, all being for use in the treatment, preservation and care of the teeth, gums and mouth;dentrifrices and non-medicated toilet preparations for cleaning the mouth;

MICRODYNAMIC

pharmaceutical preparations which facilitate drug absorption through the skin for use with a variety of medications;MICRO-DYNAMIC;non-medicated hair care preparations;

ONCE DAILY FOR MORE TIME IN MOTION

printed educational materials pertaining to the treatment of Parkinson's Disease;online information services pertaining to the treatment of Parkinson's Disease;

ONLIVEX

pharmaceutical and medicinal preparations and substances; namely, medicinal preparations for the treatment of Parkinson's disease;

ORAL HYCAMTIN

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER;ORAL;

PROREG

pharmaceutical preparations for use in treating cardiovascular related diseases and disorders;

PROTECTION RUNS IN OUR FAMILY

printed materials, namely brochures, pamphlets, and record cards concerning vaccines;information via telephone in the field of vaccines;

QUOVIR

pharmaceuticals; namely, anti-virals;

QUOVIS

pharmaceutical and medicinal preparations;

RECERNA

Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; and for vaccines;

RELUCID

pharmaceutical and medicinal preparations for the treatment of diseases and disorders of the central nervous system;

REQUIP CR

The mark consists of the literal element REQUIP CR with 3 curved lines in yellow, green and blue above the literal element.;pharmaceutical and medicinal preparations for the treatment of diseases and disorders of the central nervous system;The color(s) yellow, green, and blue is/are claimed as a feature of the mark.;CR;